Women’s Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: November 24, 2021 Report Code: GDME1260EPD-ST

Select Item

Women’s Health devices focus on the treatment and diagnosis of diseases and conditions that affect a woman’s physical and emotional well-being. GlobalData’s Medical Devices sector report provides comprehensive information about the Women’s Health Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

What are the market dynamics in the women’s health devices pipeline products market?

As of November 2021, 10 pipeline products were in the approval process and 48 were in the clinical stage. 66 pipeline products were in the inactive stage and less than 35 pipeline products were in the early development and pre-clinical stages each. During the same period, based on pipeline products by stage of development, 3 products from Agile Therapeutics Inc were in the clinical process. Similarly, Earth Science Tech Inc had 1 product in the in-approval process stage.

The US is the leading country in the market based on pipeline products by territory, followed by Europe, Israel and Canada. The other major markets in the women’s health devices pipeline products include India, Australia, China, Singapore, South Korea, the UK, Taiwan, South Africa, New Zealand, Colombia, Argentina, Brazil, Chile, Ecuador, Hong Kong, Hungary, Finland, El Salvador, Bangladesh, Costa Rica, Croatia, Nigeria, Philippines, Russia, Senegal, Kenya, Mexico, Nepal, Slovakia, and Vietnam.

Which are the key players in the women’s health devices pipeline products market?

The key players in the market are Earth Science Tech Inc, Evofem Biosciences Inc, Hera Health Solutions, Idoman Teoranta, PEPTONIC medical AB, Agile Therapeutics Inc, Advanced Tactile Imaging Inc, Dare Bioscience Inc, Materna Medical Inc., and VivoPlex Ltd. Agile Therapeutics Inc is the leading company in the market based on the pipeline products in the clinical stage, followed by Advanced Tactile Imaging Inc.

Company overview:

Earth Science Tech Inc: Earth Science Tech Inc (ETST), formerly Ultimate Novelty Sports Inc, is a biotechnology company. The company operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, and research and development. It delivers non-prescription nutritional and dietary supplements that support treating symptoms such as chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. In addition, ETST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company’s products are used in various formulations and delivery forms including capsules, tablets, soft gels, chewable, liquids, creams, sprays, powders, and whole herbs. It offers products in the areas of health, wellness, sports, and alternative medicine for consumers worldwide. ETST is headquartered in Doral, Florida, the US.

Evofem Biosciences Inc: Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention of urogenital chlamydia and gonorrhea in women. Evofem uses proprietary multi-purpose prevention technology vaginal gel to develop product candidates for multiple indications, including contraception prevention of urogenital transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis. The company concentrates on women’s sexual health and reproductive care, contraception, and the prevention of sexually transmitted infections. Evofem is headquartered in San Diego, California, the US.

PEPTONIC medical AB: Peptonic Medical AB (Peptonic) is a developer of estrogen-free products for the treatment of menopausal and postmenopausal symptoms. The company offers Vagitocin, a pharmaceutical preparation based on oxytocin that is an alternative to estrogen, which is naturally produced in the body. It conducts research on oxytocin and clinical development studies on Vagitocin. Peptonic offers to commercialize VagiVital, a hormone-free treatment for vaginal atrophy. The company also develops estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. It has operations in Vaxjo and Bromma, Sweden. Peptonic is headquartered in Stockholm, Sweden.

Agile Therapeutics Inc: Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patches containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its pipeline product candidate includes Twirla also known as AG200-15, a once-weekly prescription contraceptive patch designed using its skin fusion technology to deliver both hormones over a seven-day period. The company’s other hormonal contraceptive pipeline includes AG200-SP, a novel regimen designed to allow women to experience shorter, lighter periodsAG200-ER, an extended cycle regimen that allows a woman to extend the time between her episodes of withdrawal bleeding, and AG890 a levonorgestrel-only contraceptive patch. Agile is headquartered in Princeton, New Jersey, the US.

Dare Bioscience Inc: Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical-stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor-targeting platform, create nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body’s normal cells, and enable therapeutic combinations. Its products include ovaprene, a clinical stage, a non-hormonal contraceptive ring that provides protection over multiple weeks of use, and topical 5% sildenafil citrate cream for women with female sexual arousal disorders. The company develops and markets therapies for women in the areas of contraception, vaginal health, sexual health, and fertility. It offers services across the US. Dare Bioscience is headquartered in San Diego, California, the US.

Women’s health devices pipeline products, by key players

Women’s health devices pipeline products, by key players

To know more about key players, download a free report sample

Market report scope

Key countries/regions The US, Europe, Israel, Canada, India, Australia, China, Singapore, South Korea, the UK, Taiwan, South Africa, New Zealand, Colombia, Argentina, Brazil, Chile, Ecuador, Hong Kong, Hungary, Finland, El Salvador, Bangladesh, Costa Rica, Croatia, Nigeria, Philippines, Russia, Senegal, Kenya, Mexico, Nepal, Slovakia, and Vietnam.
Key players Earth Science Tech Inc, Evofem Biosciences Inc, Hera Health Solutions, Idoman Teoranta, PEPTONIC medical AB, Agile Therapeutics Inc, Advanced Tactile Imaging Inc, Dare Bioscience Inc, Materna Medical Inc., and VivoPlex Ltd.

Scope

  • Extensive coverage of the women’s health devices under development.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of women’s health devices and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved / issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

  • Identify and understand important and diverse types of women’s health devices under development.

  • Develop market-entry and market expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Tactile Imaging Inc
Aethlon Medical Inc
Agile Therapeutics Inc
Amniotix Technologies Ltd
ANALYTICA PTY LTD
Aneeve Nanotechnologies LLC
Astinno Ltd
Bayer AG
Baymatob Operations Pty Ltd
Baystate Medical Center
Becton Dickinson and Co
BeFree!
BioAesthetics Corp
Biorings LLC
Biostruxs LLC
Birmont Medical Ltd.
Bloomlife, Inc.
Cambridge Consultants Ltd
Cambridge Design Partner Ltd.
Cath Med Ltd.
CervoCheck, LLC
Citius Pharmaceuticals LLC
CommonSense Ltd.
CX Therapeutics Inc
Dare Bioscience Inc
Dartmouth College
Daye Ltd
DermaDiagnostics
Discreet Secrete Solutions
DS Labs, Inc
Earth Science Tech Inc
Eli Science Inc
Embryyo Technologies Pvt Ltd
Emory University
Enox Biopharma Inc (Inactive)
Evestra Inc
Evofem Biosciences Inc
Fannin Partners LLC
Femasys Inc
Ferring Pharmaceuticals AS
Fetal Life LLC
Fibro Control (Israel) Ltd (Inactive)
Fotona LLC
FP Medtech Inc
Gals Bio Ltd
Global Health Partnerships
Glyciome LLC
Grunenthal Ltd
Haemek Medical Center
Healingstone Co Ltd
Hera Health Solutions
Herbio Co Ltd
Hong Kong Polytechnic University
IcosaMed Sarl
Idoman Teoranta
Igantia Therapeutics
Imperial College London
In Veritas Medical Diagnostics Inc (Inactive)
Innometrix
Invent Medic Sweden AB
J3 Bioscience Inc
Jibon Health Technologies, Inc.
Johns Hopkins University
Joylux Inc
Keratin Biosciences Inc
KynderMed Inc
Laboratorios Andromaco
Liv Labs Inc
Madorra Inc
Magee-Womens Research Institute
Massachusetts Institute of Technology
Materna Medical Inc.
Maziwa
McGill University Health Center
Medela AG
MEDITE Cancer Diagnostics Inc (Inactive)
Medprin Regenerative Medical Technologies Co Ltd
MenoPal
Merck Serono SA
MFB Fertility Inc
Mithra Pharmaceuticals SA
Momtec Life Ltd.
Myant Inc
Nagasaki University
NaturalCycles Nordic AB
NipaYe
Nipro Corp
Northwestern University
Novela Inc
Noventure SL
OB Smart Ltd
ObsteCare AB
Obstetrx Inc
OmniBiome Therapeutics Inc
OncoGenesis
Ondine Biomedical Inc
Onko Solutions, LLC
Orion Biotechnology Canada Ltd
PEPTONIC medical AB
Pink Luminous Breast
Polumiros Inc
PolyNovo Biomaterials Pty Ltd
Positive Care Ltd
PregnanTech Ltd
Purdue University
Qurasense Inc
Rambam Health Care Campus
Reia LLC
Rejoni Inc
Renovia Inc
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
Rice University
Stanford University
Starpharma Holdings Ltd
TCM Biosciences Inc
Tecuro AG
TeVido BioDevices LLC
The Cooper Companies Inc
The Feinstein Institute for Medical Research
TruScreen Ltd
University of Auckland
University of California San Francisco
University of Duisburg-Essen
University of Erlangen-Nurnberg
University of Florida
University of Liverpool
University of Maryland Baltimore
University of Minnesota
University of Pittsburgh
University of Sheffield
University of South Florida
University of Technology of Compiegne
University of Utah
University of Waterloo
VeriTeQ Corporation
Virginia Commonwealth University
VivoPlex Ltd
Wave Intelligence Inc
Zambon Italia Srl
ZR-Operculum, Inc.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 11

|1.2 List of Figures 21

2 Introduction 22

2.1 Women’s Health Overview 22

3 Products under Development 23

3.1 Women’s Health Devices – Pipeline Products by Stage of Development 23

3.2 Women’s Health Devices – Pipeline Products by Territory 24

3.3 Women’s Health Devices – Pipeline Products by Regulatory Path 26

3.4 Women’s Health Devices – Pipeline Products by Estimated Approval Date 28

3.5 Women’s Health Devices – Ongoing Clinical Trials 29

4 Women’s Health Devices – Pipeline Products under Development by Companies 30

4.1 Women’s Health Devices Companies – Pipeline Products by Stage of Development 30

4.2 Women’s Health Devices – Pipeline Products by Stage of Development 34

5 Women’s Health Devices Companies and Product Overview 38

5.1 Advanced Tactile Imaging Inc Company Overview 38

5.1.1 Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.2 Aethlon Medical Inc Company Overview 43

5.2.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.3 Agile Therapeutics Inc Company Overview 44

5.3.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.4 Amniotix Technologies Ltd Company Overview 47

5.4.1 Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.5 ANALYTICA PTY LTD Company Overview 48

5.5.1 ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview 48

5.6 Aneeve Nanotechnologies LLC Company Overview 51

5.6.1 Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.7 Astinno Ltd Company Overview 52

5.7.1 Astinno Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.8 Bayer AG Company Overview 53

5.8.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 53

5.9 Baymatob Operations Pty Ltd Company Overview 54

5.9.1 Baymatob Operations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.10 Baystate Medical Center Company Overview 55

5.10.1 Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55

5.11 Becton Dickinson and Co Company Overview 56

5.11.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 56

5.12 BeFree! Company Overview 60

5.12.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview 60

5.13 BioAesthetics Corp Company Overview 61

5.13.1 BioAesthetics Corp Pipeline Products & Ongoing Clinical Trials Overview 61

5.14 Biorings LLC Company Overview 65

5.14.1 Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.15 Biostruxs LLC Company Overview 66

5.15.1 Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 66

5.16 Birmont Medical Ltd. Company Overview 67

5.16.1 Birmont Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

5.17 Bloomlife, Inc. Company Overview 68

5.17.1 Bloomlife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.18 Cambridge Consultants Ltd Company Overview 69

5.18.1 Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.19 Cambridge Design Partner Ltd. Company Overview 70

5.19.1 Cambridge Design Partner Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

5.20 Cath Med Ltd. Company Overview 71

5.20.1 Cath Med Ltd. Pipeline Products & Ongoing Clinical Trials Overview 71

5.21 CervoCheck, LLC Company Overview 72

5.21.1 CervoCheck, LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.22 Citius Pharmaceuticals LLC Company Overview 73

5.22.1 Citius Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 73

5.23 CommonSense Ltd. Company Overview 74

5.23.1 CommonSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74

5.24 CX Therapeutics Inc Company Overview 75

5.24.1 CX Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.25 Dare Bioscience Inc Company Overview 76

5.25.1 Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.26 Dartmouth College Company Overview 78

5.26.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 78

5.27 Daye Ltd Company Overview 80

5.27.1 Daye Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.28 DermaDiagnostics Company Overview 81

5.28.1 DermaDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 81

5.29 Discreet Secrete Solutions Company Overview 82

5.29.1 Discreet Secrete Solutions Pipeline Products & Ongoing Clinical Trials Overview 82

5.30 DS Labs, Inc Company Overview 83

5.30.1 DS Labs, Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.31 Earth Science Tech Inc Company Overview 84

5.31.1 Earth Science Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.32 Eli Science Inc Company Overview 86

5.32.1 Eli Science Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.33 Embryyo Technologies Pvt Ltd Company Overview 87

5.33.1 Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

5.34 Emory University Company Overview 88

5.34.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 88

5.35 Enox Biopharma Inc (Inactive) Company Overview 89

5.35.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89

5.36 Evestra Inc Company Overview 90

5.36.1 Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.37 Evofem Biosciences Inc Company Overview 91

5.37.1 Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.38 Fannin Partners LLC Company Overview 93

5.38.1 Fannin Partners LLC Pipeline Products & Ongoing Clinical Trials Overview 93

5.39 Femasys Inc Company Overview 94

5.39.1 Femasys Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.40 Ferring Pharmaceuticals AS Company Overview 98

5.40.1 Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview 98

5.41 Fetal Life LLC Company Overview 99

5.41.1 Fetal Life LLC Pipeline Products & Ongoing Clinical Trials Overview 99

5.42 Fibro Control (Israel) Ltd (Inactive) Company Overview 102

5.42.1 Fibro Control (Israel) Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 102

5.43 Fotona LLC Company Overview 103

5.43.1 Fotona LLC Pipeline Products & Ongoing Clinical Trials Overview 103

5.44 FP Medtech Inc Company Overview 104

5.44.1 FP Medtech Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.45 Gals Bio Ltd Company Overview 105

5.45.1 Gals Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.46 Global Health Partnerships Company Overview 108

5.46.1 Global Health Partnerships Pipeline Products & Ongoing Clinical Trials Overview 108

5.47 Glyciome LLC Company Overview 109

5.47.1 Glyciome LLC Pipeline Products & Ongoing Clinical Trials Overview 109

5.48 Grunenthal Ltd Company Overview 110

5.48.1 Grunenthal Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.49 Haemek Medical Center Company Overview 111

5.49.1 Haemek Medical Center Pipeline Products & Ongoing Clinical Trials Overview 111

5.50 Healingstone Co Ltd Company Overview 112

5.50.1 Healingstone Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

5.51 Hera Health Solutions Company Overview 113

5.51.1 Hera Health Solutions Pipeline Products & Ongoing Clinical Trials Overview 113

5.52 Herbio Co Ltd Company Overview 114

5.52.1 Herbio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

5.53 Hong Kong Polytechnic University Company Overview 115

5.53.1 Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview 115

5.54 IcosaMed Sarl Company Overview 116

5.54.1 IcosaMed Sarl Pipeline Products & Ongoing Clinical Trials Overview 116

5.55 Idoman Teoranta Company Overview 117

5.55.1 Idoman Teoranta Pipeline Products & Ongoing Clinical Trials Overview 117

5.56 Igantia Therapeutics Company Overview 118

5.56.1 Igantia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 118

5.57 Imperial College London Company Overview 119

5.57.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 119

5.58 In Veritas Medical Diagnostics Inc (Inactive) Company Overview 120

5.58.1 In Veritas Medical Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120

5.59 Innometrix Company Overview 121

5.59.1 Innometrix Pipeline Products & Ongoing Clinical Trials Overview 121

5.60 Invent Medic Sweden AB Company Overview 122

5.60.1 Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 122

5.61 J3 Bioscience Inc Company Overview 123

5.61.1 J3 Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 123

5.62 Jibon Health Technologies, Inc. Company Overview 125

5.62.1 Jibon Health Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125

5.63 Johns Hopkins University Company Overview 126

5.63.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 126

5.64 Joylux Inc Company Overview 127

5.64.1 Joylux Inc Pipeline Products & Ongoing Clinical Trials Overview 127

5.65 Keratin Biosciences Inc Company Overview 128

5.65.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.66 KynderMed Inc Company Overview 129

5.66.1 KynderMed Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.67 Laboratorios Andromaco Company Overview 132

5.67.1 Laboratorios Andromaco Pipeline Products & Ongoing Clinical Trials Overview 132

5.68 Liv Labs Inc Company Overview 133

5.68.1 Liv Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 133

5.69 Madorra Inc Company Overview 134

5.69.1 Madorra Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.70 Magee-Womens Research Institute Company Overview 135

5.70.1 Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview 135

5.71 Massachusetts Institute of Technology Company Overview 136

5.71.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 136

5.72 Materna Medical Inc. Company Overview 137

5.72.1 Materna Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 137

5.73 Maziwa Company Overview 141

5.73.1 Maziwa Pipeline Products & Ongoing Clinical Trials Overview 141

5.74 McGill University Health Center Company Overview 142

5.74.1 McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 142

5.75 Medela AG Company Overview 143

5.75.1 Medela AG Pipeline Products & Ongoing Clinical Trials Overview 143

5.76 MEDITE Cancer Diagnostics Inc (Inactive) Company Overview 144

5.76.1 MEDITE Cancer Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 144

5.77 Medprin Regenerative Medical Technologies Co Ltd Company Overview 145

5.77.1 Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145

5.78 MenoPal Company Overview 146

5.78.1 MenoPal Pipeline Products & Ongoing Clinical Trials Overview 146

5.79 Merck Serono SA Company Overview 147

5.79.1 Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview 147

5.80 MFB Fertility Inc Company Overview 148

5.80.1 MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview 148

5.81 Mithra Pharmaceuticals SA Company Overview 149

5.81.1 Mithra Pharmaceuticals SA Pipeline Products & Ongoing Clinical Trials Overview 149

5.82 Momtec Life Ltd. Company Overview 150

5.82.1 Momtec Life Ltd. Pipeline Products & Ongoing Clinical Trials Overview 150

5.83 Myant Inc Company Overview 151

5.83.1 Myant Inc Pipeline Products & Ongoing Clinical Trials Overview 151

5.84 Nagasaki University Company Overview 152

5.84.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 152

5.85 NaturalCycles Nordic AB Company Overview 153

5.85.1 NaturalCycles Nordic AB Pipeline Products & Ongoing Clinical Trials Overview 153

5.86 NipaYe Company Overview 154

5.86.1 NipaYe Pipeline Products & Ongoing Clinical Trials Overview 154

5.87 Nipro Corp Company Overview 155

5.87.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 155

5.88 Northwestern University Company Overview 156

5.88.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 156

5.89 Novela Inc Company Overview 158

5.89.1 Novela Inc Pipeline Products & Ongoing Clinical Trials Overview 158

5.90 Noventure SL Company Overview 159

5.90.1 Noventure SL Pipeline Products & Ongoing Clinical Trials Overview 159

5.91 OB Smart Ltd Company Overview 160

5.91.1 OB Smart Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

5.92 ObsteCare AB Company Overview 161

5.92.1 ObsteCare AB Pipeline Products & Ongoing Clinical Trials Overview 161

5.93 Obstetrx Inc Company Overview 162

5.93.1 Obstetrx Inc Pipeline Products & Ongoing Clinical Trials Overview 162

5.94 OmniBiome Therapeutics Inc Company Overview 163

5.94.1 OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 163

5.95 OncoGenesis Company Overview 164

5.95.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 164

5.96 Ondine Biomedical Inc Company Overview 165

5.96.1 Ondine Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 165

5.97 Onko Solutions, LLC Company Overview 166

5.97.1 Onko Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 166

5.98 Orion Biotechnology Canada Ltd Company Overview 167

5.98.1 Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

5.99 PEPTONIC medical AB Company Overview 168

5.99.1 PEPTONIC medical AB Pipeline Products & Ongoing Clinical Trials Overview 168

5.100 Pink Luminous Breast Company Overview 173

5.100.1 Pink Luminous Breast Pipeline Products & Ongoing Clinical Trials Overview 173

5.101 Polumiros Inc Company Overview 174

5.101.1 Polumiros Inc Pipeline Products & Ongoing Clinical Trials Overview 174

5.102 PolyNovo Biomaterials Pty Ltd Company Overview 175

5.102.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

5.103 Positive Care Ltd Company Overview 176

5.103.1 Positive Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

5.104 PregnanTech Ltd Company Overview 177

5.104.1 PregnanTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 177

5.105 Purdue University Company Overview 178

5.105.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 178

5.106 Qurasense Inc Company Overview 179

5.106.1 Qurasense Inc Pipeline Products & Ongoing Clinical Trials Overview 179

5.107 Rambam Health Care Campus Company Overview 182

5.107.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 182

5.108 Reia LLC Company Overview 183

5.108.1 Reia LLC Pipeline Products & Ongoing Clinical Trials Overview 183

5.109 Rejoni Inc Company Overview 184

5.109.1 Rejoni Inc Pipeline Products & Ongoing Clinical Trials Overview 184

5.110 Renovia Inc Company Overview 185

5.110.1 Renovia Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.111 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 189

5.111.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 189

5.112 Rice University Company Overview 190

5.112.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 190

5.113 Stanford University Company Overview 192

5.113.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 192

5.114 Starpharma Holdings Ltd Company Overview 193

5.114.1 Starpharma Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 193

5.115 TCM Biosciences Inc Company Overview 194

5.115.1 TCM Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 194

5.116 Tecuro AG Company Overview 195

5.116.1 Tecuro AG Pipeline Products & Ongoing Clinical Trials Overview 195

5.117 TeVido BioDevices LLC Company Overview 196

5.117.1 TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 196

5.118 The Cooper Companies Inc Company Overview 198

5.118.1 The Cooper Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 198

5.119 The Feinstein Institute for Medical Research Company Overview 199

5.119.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 199

5.120 TruScreen Ltd Company Overview 200

5.120.1 TruScreen Ltd Pipeline Products & Ongoing Clinical Trials Overview 200

5.121 University of Auckland Company Overview 201

5.121.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 201

5.122 University of California San Francisco Company Overview 202

5.122.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 202

5.123 University of Duisburg-Essen Company Overview 203

5.123.1 University of Duisburg-Essen Pipeline Products & Ongoing Clinical Trials Overview 203

5.124 University of Erlangen-Nurnberg Company Overview 204

5.124.1 University of Erlangen-Nurnberg Pipeline Products & Ongoing Clinical Trials Overview 204

5.125 University of Florida Company Overview 205

5.125.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 205

5.126 University of Liverpool Company Overview 207

5.126.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 207

5.127 University of Maryland Baltimore Company Overview 210

5.127.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 210

5.128 University of Minnesota Company Overview 211

5.128.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 211

5.129 University of Pittsburgh Company Overview 213

5.129.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 213

5.130 University of Sheffield Company Overview 214

5.130.1 University of Sheffield Pipeline Products & Ongoing Clinical Trials Overview 214

5.131 University of South Florida Company Overview 215

5.131.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 215

5.132 University of Technology of Compiegne Company Overview 218

5.132.1 University of Technology of Compiegne Pipeline Products & Ongoing Clinical Trials Overview 218

5.133 University of Utah Company Overview 219

5.133.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 219

5.134 University of Waterloo Company Overview 220

5.134.1 University of Waterloo Pipeline Products & Ongoing Clinical Trials Overview 220

5.135 VeriTeQ Corporation Company Overview 221

5.135.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 221

5.136 Virginia Commonwealth University Company Overview 222

5.136.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 222

5.137 VivoPlex Ltd Company Overview 223

5.137.1 VivoPlex Ltd Pipeline Products & Ongoing Clinical Trials Overview 223

5.138 Wave Intelligence Inc Company Overview 226

5.138.1 Wave Intelligence Inc Pipeline Products & Ongoing Clinical Trials Overview 226

5.139 Zambon Italia Srl Company Overview 227

5.139.1 Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview 227

5.140 ZR-Operculum, Inc. Company Overview 228

5.140.1 ZR-Operculum, Inc. Pipeline Products & Ongoing Clinical Trials Overview 228

6 Women’s Health- Recent Developments 229

6.1 Nov 18, 2021: Clinical Data Shows the Efficacy of In-Phase and Quadrature Demodulation in Electronic Fetal Heart Rate Monitoring During Labor 229

6.2 Nov 15, 2021: Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update 229

6.3 Nov 11, 2021: Piramal Enterprises Announces Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September, 2021 230

6.4 Nov 11, 2021: Piramal Enterprises announces Report Of The Auditors On Financial Results For The Quarter And Half Year Ended 30Th September, 2021 231

6.5 Nov 10, 2021: Mithra organizes its Investor Day on November 29, 2021 232

6.6 Nov 10, 2021: Femasys Announces Financial Results for the Third Quarter of 2021 232

6.7 Nov 09, 2021: Rodrigo Santos Named Member of the Board of Management, Bayer AG, and President of the Crop Science Division 233

6.8 Nov 09, 2021: Coloplast Notice of Annual General Meeting 234

6.9 Nov 09, 2021: Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update 234

6.10 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 236

6.11 Nov 04, 2021: Bayer announces Christoph Koenen as new Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer 236

6.12 Nov 04, 2021: Quidel Reports Third Quarter 2021 Financial Results 236

6.13 Nov 02, 2021: CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2021 239

6.14 Nov 01, 2021: Coloplast Announces Full-year Financial Results 2020/21 239

6.15 Nov 01, 2021: Coloplast delivers solid full year results in line with the company’s financial guidance after a strong Q4 performance 240

6.16 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 242

6.17 Oct 26, 2021: BD to Host Investor Day on November 12 246

6.18 Oct 25, 2021: Memphasys : $1.36 million R&D rebate received and patent position strengthened 246

6.19 Oct 22, 2021: Physiomics: Contract awards 247

6.20 Oct 19, 2021: Vitrolife announce conference call interim report 247

6.21 Oct 18, 2021: BD launches New ‘Together We Advance’ Environmental, Social, Governance Strategy; Announces 2030+ Goals to Enhance Stewardship of Human Health, Communities and the Planet 247

6.22 Oct 14, 2021: INVO Bioscience announces grand opening of “Positib Fertility, an INVO Center” in Monterrey, Mexico 249

6.23 Oct 07, 2021: Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021 250

6.24 Oct 05, 2021: Bayer to invest over €400 million to increase access to modern contraception 250

6.25 Sep 30, 2021: Aspira Women’s Health, Black Women’s Health Imperative lead congressional briefing 251

6.26 Sep 24, 2021: Mithra announces 2021 half year results 252

6.27 Sep 23, 2021: Femasys to Present at The MedTech Conference 253

6.28 Sep 20, 2021: Memphasys: Progress accelerates for reproductive biotechnology portfolio 253

6.29 Sep 14, 2021: EKF Diagnostics Holdings Announces unaudited interim results for the six months ended 30 June 2021 254

6.30 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 255

6.31 Sep 07, 2021: Mckesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director 255

6.32 Sep 02, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 256

6.33 Aug 24, 2021: ImpediMed : Receipt of $1.8 million R&D tax incentive refund 256

6.34 Aug 18, 2021: Coloplast delivers 11% organic growth in Q3 and an EBIT margin of 33% 256

6.35 Aug 17, 2021: NanoVibronix Announces Results of Annual Meeting of Stockholders Held 257

6.36 Aug 16, 2021: McKesson to Host Investor Day on December 8, 2021 258

6.37 Aug 13, 2021: Atossa Therapeutics Announces Second Quarter 2021 Financial Results Provides Corporate Update and Information about Upcoming Stockholder Meeting 258

6.38 Aug 11, 2021: Hartmann’s announce Sales and earnings under pressure 260

6.39 Aug 11, 2021: Femasys Announces Financial Results for the Second Quarter of 2021 260

6.40 Aug 11, 2021: WHO launches Solidarity PLUS to assess three new drugs for Covid-19 261

6.41 Aug 10, 2021: Sientra Reports Record Breast Products Revenue for Second Quarter 2021, Raises Revenue Guidance for Full Year 2021 262

6.42 Aug 09, 2021: Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update 264

6.43 Aug 07, 2021: Piramal Enterprises Announces Unaudited Financial Results For The Quarter Ended 30Th June, 2021 265

6.44 Aug 06, 2021: Piramal Enterprises Announces Consolidated Results for Q1 FY2022 265

6.45 Aug 05, 2021: INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021 266

6.46 Aug 04, 2021: McKesson Reports Fiscal 2022 First-Quarter Results 266

6.47 Jul 29, 2021: Ontex Group reports results for six months ending June 30, 2021 266

6.48 Jul 29, 2021: Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021 267

6.49 Jul 29, 2021: BD to Present at UBS Genomics

2.0 and MedTech Innovations Summit 268

6.50 Jul 29, 2021: CooperCompanies Announces Release Date for Third Quarter 2021 268

6.51 Jul 28, 2021: Avery Dennison Announces Second Quarter 2021 Results 268

6.52 Jul 28, 2021: Hologic Announces Financial Results for Third Quarter of Fiscal 2021 270

6.53 Jul 19, 2021: Hera Med: Change of registered office 272

6.54 Jul 12, 2021: Sientra Announces Appointment of Chief Financial Officer 272

6.55 Jul 01, 2021: Coloplast delivers 11% organic growth in Q3 and an EBIT margin of 33% Organic growth in Q3 was 11% and reported revenue in DKK was up by 9% to DKK 4,835 million 272

6.56 Jun 24, 2021: James Cook University scientists believe they have made a breakthrough in the science of keeping premature babies alive 274

6.57 Jun 24, 2021: Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update 275

6.58 Jun 03, 2021: CooperCompanies Announces Second Quarter 2021 Results 276

6.59 May 26, 2021: Bayer joins Greentown Labs’ Corporate Partner Network 277

6.60 May 24, 2021: Boston Scientific to Participate in Bernstein’s 37th Annual Strategic Decisions Conference 278

6.61 May 20, 2021: Drexel Names New Center on Racism and Health, Center Director 278

6.62 May 17, 2021: The Center for Innovative GYN Care presents at three key industry conferences 279

6.63 May 14, 2021: Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update 280

6.64 May 11, 2021: Huons Global 1Q solid results; Sales of KRW

131.6 billion, an increase of 13% from the previous year 281

6.65 May 10, 2021: Northwestern University: Scientists develop first wireless sensors to monitor pregnant women and their babies 282

6.66 May 06, 2021: McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results 284

6.67 May 03, 2021: Huons USA Appoints Jae-Myung Choi, CEO of’Overseas Communication’ 287

6.68 Apr 29, 2021: Granted U.S. patents further strengthens MEM I.P. portfolio 287

6.69 Apr 28, 2021: Ontex Announces Executive Management Committee Appointments: Peter Vanneste as Chief Financial Officer and Vincent Crepy as Chief Supply Chain Officer 288

6.70 Apr 28, 2021: Ontex Q1 2021 Trading Update: Revenue and Operating Margin Down in the Context of Soft Demand, Leadership Appointments to Drive Turnaround 289

6.71 Apr 28, 2021: Avery Dennison Announces First Quarter 2021 Results 292

6.72 Apr 28, 2021: Report from Annual General Meeting of Vitrolife AB (publ) 293

6.73 Apr 28, 2021: Hologic Announces Financial Results for Second Quarter of Fiscal 2021 294

6.74 Apr 23, 2021: EKF Diagnostics Holdings Announces Annual Report & Accounts And Notice of Annal General Meeting 295

6.75 Apr 22, 2021: Quidel Announces Preliminary Revenue for First Quarter 2021 295

6.76 Apr 22, 2021: LiquidGoldConcept receives NIH grant for lactation support training technology 296

6.77 Apr 05, 2021: BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021 297

6.78 Mar 31, 2021: Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update 297

6.79 Mar 24, 2021: Notice of Annual General Meeting of Vitrolife 298

6.80 Mar 24, 2021: Hysterectomy used more for postpartum bleeding compared to less invasive option 299

6.81 Mar 22, 2021: Ontada Appoints Susan Shiff, Ph.D., MBA, as President 300

6.82 Mar 19, 2021: Huons Group Holds General Shareholders Meeting 300

6.83 Mar 16, 2021: CRH Medical announces 2020 Q4 and year-end results 301

6.84 Mar 12, 2021: Sientra Reports Fourth Quarter and Full Year 2020 Financial Results 301

6.85 Mar 11, 2021: INVO Bioscience to Participate in the 33rd Annual Roth Conference 303

6.86 Mar 11, 2021: Sientra Announces Departure of CFO and Appointment of Interim CFO 304

6.87 Mar 08, 2021: U of M Vice President for Research Chris Cramer announces departure from the University for national research opportunity 304

6.88 Mar 04, 2021: Mithra to Host Webcast for 2020 Financial Results on 9 March 2021 305

6.89 Mar 04, 2021: CooperCompanies Announces First Quarter 2021 Results 305

6.90 Mar 04, 2021: World University Of Design along with IIT New Delhi And AIIMS creates Mamma Pod Garment 307

6.91 Mar 01, 2021: Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences 307

6.92 Feb 25, 2021: MERCK REPORTS Info Financial Results 2020 307

6.93 Feb 25, 2021: Sientra to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021 308

6.94 Feb 24, 2021: Poxel announces completion of Arbitration with Merck Serono 308

6.95 Feb 24, 2021: Thermo Fisher Scientific to Present at 41st Annual Cowen Healthcare Conference on March 3, 2021 308

6.96 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees 308

6.97 Feb 19, 2021: Ontex announces details for its FY 2020 results and webcast 309

6.98 Feb 18, 2021: Quidel Reports Fourth Quarter and Full Year 2020 Financial Results 309

6.99 Feb 17, 2021: U of M’s Technological Leadership Institute names Professor Allison Hubel new director 311

6.100 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil 312

6.101 Feb 12, 2021: BD to Present at Upcoming Investor Conferences 313

6.102 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule 313

6.103 Feb 11, 2021: Sientra to Present at the SVB Leerink 10th Annual Global Healthcare Conference 313

6.104 Feb 10, 2021: Vitrolife AB ADR reports Q4 results 313

6.105 Feb 10, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 313

6.106 Feb 10, 2021: Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update 314

6.107 Feb 04, 2021: Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021 315

6.108 Feb 04, 2021: Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results 316

6.109 Feb 04, 2021: The Board of Directors appoints Leon Van Rompay as CEO ad interim 316

6.110 Feb 04, 2021: Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021 317

6.111 Feb 02, 2021: McKesson Reports Fiscal 2021 Third-Quarter Results 317

6.112 Feb 01, 2021: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2020 Results 319

6.113 Jan 28, 2021: Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021 322

6.114 Jan 27, 2021: Hologic FQ1 2021 Earnings Preview 322

6.115 Jan 22, 2021: Conference call Report on Operations 2020 Vitrolife 322

6.116 Jan 21, 2021: Avery Dennison Announces Upcoming Investor Events 323

6.117 Jan 20, 2021: Essity launches absorbent underwear for menstruation and incontinence 323

6.118 Jan 12, 2021: Mithra Announces 2021 Financial Calendar 324

6.119 Jan 04, 2021: Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference 324

6.120 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience 324

6.121 Dec 22, 2020: CRH Medical announces customer update 324

6.122 Dec 07, 2020: Study finds no change in preterm birth or stillbirth in Philadelphia during pandemic period 324

7 Appendix 326

7.1 Methodology 326

7.2 About GlobalData 329

7.3 Contact Us 329

Table

Women’s Health Devices – Pipeline Products by Stage of Development 23

Women’s Health Devices – Pipeline Products by Territory 24

Women’s Health Devices – Pipeline Products by Regulatory Path 26

Women’s Health Devices – Pipeline Products by Estimated Approval Date 28

Women’s Health Devices – Ongoing Clinical Trials 29

Women’s Health Companies – Pipeline Products by Stage of Development 30

Women’s Health Devices – Pipeline Products by Stage of Development 34

Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Antepartum Tactile Imager – Product Status 38

Antepartum Tactile Imager – Product Description 38

Cervix Monitor – Product Status 39

Cervix Monitor – Product Description 39

Restore-IT – Product Status 39

Restore-IT – Product Description 40

Vaginal Ultrasound Imager – Product Status 40

Vaginal Ultrasound Imager – Product Description 40

Advanced Tactile Imaging Inc – Ongoing Clinical Trials Overview 41

Cervix Monitor – Cervix Monitor for Elasticity and Length Measurements 42

Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 43

HER2osome – Product Status 43

HER2osome – Product Description 43

Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 44

AG200-ER Patch – Product Status 44

AG200-ER Patch – Product Description 45

AG200-SP Patch – Product Status 45

AG200-SP Patch – Product Description 45

AG890 Patch – Product Status 46

AG890 Patch – Product Description 46

Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Amniotic Fluid Spectral Monitoring Device – Product Status 47

Amniotic Fluid Spectral Monitoring Device – Product Description 47

ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview 48

PeriCoach System – Product Status 48

PeriCoach System – Product Description 48

ANALYTICA PTY LTD – Ongoing Clinical Trials Overview 49

PeriCoach System – Study of PeriCoach Efficacy in Stress Urinary Incontinence and Sexual 50

Function 50

Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 51

Hormone Sensor – Product Status 51

Hormone Sensor – Product Description 51

Astinno Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Grace – Product Status 52

Grace – Product Description 52

Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 53

Next-Generation Essure Device – Product Status 53

Next-Generation Essure Device – Product Description 53

Baymatob Operations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

Oli – Product Status 54

Oli – Product Description 54

Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55

Expandable Pessaries – Product Status 55

Expandable Pessaries – Product Description 55

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 56

BD Odon Device – Product Status 56

BD Odon Device – Product Description 57

Becton Dickinson and Co – Ongoing Clinical Trials Overview 58

BD Odon Device – The BD Odon Device for Assisted Vaginal Birth: A Feasibility Study to Investigate Safety and Efficacy 59

BeFree! Pipeline Products & Ongoing Clinical Trials Overview 60

Vaginal Drug Delivery System – Product Status 60

Vaginal Drug Delivery System – Product Description 60

BioAesthetics Corp Pipeline Products & Ongoing Clinical Trials Overview 61

Acellular Biologic Graft – Pelvic Organ Prolapse – Product Status 61

Acellular Biologic Graft – Pelvic Organ Prolapse – Product Description 61

Acellular NAC Graft – Product Status 62

Acellular NAC Graft – Product Description 62

BioAesthetics Corp – Ongoing Clinical Trials Overview 63

Acellular NAC Graft – A Single Arm, Single Center Pilot Study Evaluating the Safety and Healing Time of a Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Graft 64

Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview 65

Vaginal Ring – Product Status 65

Vaginal Ring – Product Description 65

Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 66

BioBreast Scaffold – Product Status 66

BioBreast Scaffold – Product Description 66

Birmont Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

Labor Progression Monitoring Device – Product Status 67

Labor Progression Monitoring Device – Product Description 67

Bloomlife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

Wearable Integrated System – Preterm Birth Detection – Product Status 68

Wearable Integrated System – Preterm Birth Detection – Product Description 68

Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

Pebl Device – Product Status 69

Pebl Device – Product Description 69

Cambridge Design Partner Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

Uterine Balloon Tamponade – Product Status 70

Uterine Balloon Tamponade – Product Description 70

Cath Med Ltd. Pipeline Products & Ongoing Clinical Trials Overview 71

Chorionic Villus Sampling Trans-Cervical Catheter – Product Status 71

Chorionic Villus Sampling Trans-Cervical Catheter – Product Description 71

CervoCheck, LLC Pipeline Products & Ongoing Clinical Trials Overview 72

CervoCheck – Product Status 72

CervoCheck – Product Description 72

Citius Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 73

Mino-Wrap – Product Status 73

Mino-Wrap – Product Description 73

CommonSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74

Sensing Tampons – Women – Product Status 74

Sensing Tampons – Women – Product Description 74

CX Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 75

Cervical Support Device – Product Status 75

Cervical Support Device – Product Description 75

Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 76

DARE-VVA1 Intravaginal Ring – Product Status 76

DARE-VVA1 Intravaginal Ring – Product Description 76

Ovaprene – Product Status 77

Ovaprene – Product Description 77

Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 78

Magnetic Particle Heating System – Product Status 78

Magnetic Particle Heating System – Product Description 78

Nanotherapeutic Device – Product Status 79

Nanotherapeutic Device – Product Description 79

Daye Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

CBD Tampon – Product Status 80

CBD Tampon – Product Description 80

DermaDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 81

Diapatch – Cervical Cancer – Product Status 81

Diapatch – Cervical Cancer – Product Description 81

Discreet Secrete Solutions Pipeline Products & Ongoing Clinical Trials Overview 82

Freedom Pump – Product Status 82

Freedom Pump – Product Description 82

DS Labs, Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Gala Pump – Product Status 83

Gala Pump – Product Description 83

Earth Science Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 84

Hygee – Product Status 84

Hygee – Product Description 85

Eli Science Inc Pipeline Products & Ongoing Clinical Trials Overview 86

At Home Hormone Monitoring Device – Product Status 86

At Home Hormone Monitoring Device – Product Description 86

Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

Cephalopelvic Disproportion Assessment Device – Product Status 87

Cephalopelvic Disproportion Assessment Device – Product Description 87

Emory University Pipeline Products & Ongoing Clinical Trials Overview 88

Obstrix – Product Status 88

Obstrix – Product Description 88

Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 89

Intra-Vaginal Implant – Product Status 89

Intra-Vaginal Implant – Product Description 89

Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Vaginal Ring For Preterm Labor – Product Status 90

Vaginal Ring For Preterm Labor – Product Description 90

Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 91

Amphora – Product Status 91

Amphora – Product Description 91

EVO100 – Product Status 92

EVO100 – Product Description 92

Fannin Partners LLC Pipeline Products & Ongoing Clinical Trials Overview 93

ChorioAnchor – Product Status 93

ChorioAnchor – Product Description 93

Femasys Inc Pipeline Products & Ongoing Clinical Trials Overview 94

FemaSeed Insemination Catheter – Product Status 94

FemaSeed Insemination Catheter – Product Description 94

FemCav Endometrial Sampler – Product Status 95

FemCav Endometrial Sampler – Product Description 95

Femasys Inc – Ongoing Clinical Trials Overview 96

FemaSeed Insemination Catheter – LOCAL: Prospective Multi-center Localized Directional Insemination Trial for Artificial Insemination 97

Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview 98

Premis Vaginal Insert – Product Status 98

Premis Vaginal Insert – Product Description 98

Fetal Life LLC Pipeline Products & Ongoing Clinical Trials Overview 99

Tocometer Device – Product Status 99

Tocometer Device – Product Description 99

Fetal Life LLC – Ongoing Clinical Trials Overview 100

Tocometer Device – Fetal Life: Calibration, Noninferiority and Feasibility Studies for Smart-device Based Uterine Activity Monitoring 101

Fibro Control (Israel) Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 102

Uterine Fibroid Occlusion Device – Product Status 102

Uterine Fibroid Occlusion Device – Product Description 102

Fotona LLC Pipeline Products & Ongoing Clinical Trials Overview 103

RenovaLase – Product Status 103

RenovaLase – Product Description 103

FP Medtech Inc Pipeline Products & Ongoing Clinical Trials Overview 104

Vaginal Measurement Device – Product Status 104

Vaginal Measurement Device – Product Description 104

Gals Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

Tulipon – Product Status 105

Tulipon – Product Description 105

Gals Bio Ltd – Ongoing Clinical Trials Overview 106

Tulipon – A Single-center Study Designed to Evaluate the Safety and Efficacy of a New Hygienic Device, Tulipon, in Adult Females with Normal Monthly Menstruation 107

Global Health Partnerships Pipeline Products & Ongoing Clinical Trials Overview 108

Circumferential Abdominal-Pelvic Pressure (CAPP) Device – Product Status 108

Circumferential Abdominal-Pelvic Pressure (CAPP) Device – Product Description 108

Glyciome LLC Pipeline Products & Ongoing Clinical Trials Overview 109

PreBioGyn – Product Status 109

PreBioGyn – Product Description 109

Grunenthal Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

Fertiring – Product Status 110

Fertiring – Product Description 110

Haemek Medical Center Pipeline Products & Ongoing Clinical Trials Overview 111

Breast Cancer Screening Bra – Product Status 111

Breast Cancer Screening Bra – Product Description 111

Healingstone Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

Healingstone Navel Belt – Product Status 112

Healingstone Navel Belt – Product Description 112

Hera Health Solutions Pipeline Products & Ongoing Clinical Trials Overview 113

Eucontra – Product Status 113

Eucontra – Product Description 113

Herbio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

Picot – Product Status 114

Picot – Product Description 114

Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview 115

Post-Mastectomy Undergarment – Product Status 115

Post-Mastectomy Undergarment – Product Description 115

IcosaMed Sarl Pipeline Products & Ongoing Clinical Trials Overview 116

Smart Bra – Product Status 116

Smart Bra – Product Description 116

Idoman Teoranta Pipeline Products & Ongoing Clinical Trials Overview 117

Thermablate EAS – Product Status 117

Thermablate EAS – Product Description 117

Igantia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 118

Hot Flashes Treatment Device – Product Status 118

Hot Flashes Treatment Device – Product Description 118

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 119

Wireless Bio-Patch – Product Status 119

Wireless Bio-Patch – Product Description 119

In Veritas Medical Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 120

Labor Predictor – Professional – Product Status 120

Labor Predictor – Professional – Product Description 120

Innometrix Pipeline Products & Ongoing Clinical Trials Overview 121

GynMech – Product Status 121

GynMech – Product Description 121

Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 122

Efemia Menstrual Cup – Product Status 122

Efemia Menstrual Cup – Product Description 122

J3 Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 123

pH Balancing Ring – Product Status 123

pH Balancing Ring – Product Description 123

Probiotic Ring – Product Status 124

Probiotic Ring – Product Description 124

Jibon Health Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125

Tampostat Device – Product Status 125

Tampostat Device – Product Description 125

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 126

TocoTrack – Product Status 126

TocoTrack – Product Description 126

Joylux Inc Pipeline Products & Ongoing Clinical Trials Overview 127

vSculpt – Product Status 127

vSculpt – Product Description 127

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 128

Microchip-Based Contraceptive Implant – Product Status 128

Microchip-Based Contraceptive Implant – Product Description 128

KynderMed Inc Pipeline Products & Ongoing Clinical Trials Overview 129

Ocular Light – Product Status 129

Ocular Light – Product Description 129

KynderMed Inc – Ongoing Clinical Trials Overview 130

Ocular Light – Nightly Suppression of Contractions in At-Risk Pregnancies by the Infusion of Defused Blue Light 131

Laboratorios Andromaco Pipeline Products & Ongoing Clinical Trials Overview 132

Progering – Product Status 132

Progering – Product Description 132

Liv Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 133

Soft Spring Continence Pessary – Product Status 133

Soft Spring Continence Pessary – Product Description 133

Madorra Inc Pipeline Products & Ongoing Clinical Trials Overview 134

Non-Hormonal Device – Product Status 134

Non-Hormonal Device – Product Description 134

Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview 135

Pelvic Organ Prolapse Mesh – Product Status 135

Pelvic Organ Prolapse Mesh – Product Description 135

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 136

Vaginal Delivery Device – Product Status 136

Vaginal Delivery Device – Product Description 136

Materna Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 137

Materna Prep – Product Status 137

Materna Prep – Product Description 137

Milli – Product Status 138

Milli – Product Description 138

Materna Medical Inc. – Ongoing Clinical Trials Overview 139

Materna Prep – A Clinical Phase II Study of the Materna Device to Shorten Delivery Time During Childbirth 140

Maziwa Pipeline Products & Ongoing Clinical Trials Overview 141

Breast Pump – Product Status 141

Breast Pump – Product Description 141

McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 142

Wearable Pendant – Product Status 142

Wearable Pendant – Product Description 142

Medela AG Pipeline Products & Ongoing Clinical Trials Overview 143

Fluid Filled Single Breast Pump – Product Status 143

Fluid Filled Single Breast Pump – Product Description 143

MEDITE Cancer Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 144

BreastPap – Product Status 144

BreastPap – Product Description 144

Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145

Female Pelvic Diaphragm Repair System – Product Status 145

Female Pelvic Diaphragm Repair System – Product Description 145

MenoPal Pipeline Products & Ongoing Clinical Trials Overview 146

Menopal Device – Product Status 146

Menopal Device – Product Description 146

Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview 147

MK-8342 Medicated IUS – Product Status 147

MK-8342 Medicated IUS – Product Description 147

MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview 148

Hormone HELP Monitor – Product Status 148

Hormone HELP Monitor – Product Description 148

Mithra Pharmaceuticals SA Pipeline Products & Ongoing Clinical Trials Overview 149

Alyssa – Product Status 149

Alyssa – Product Description 149

Momtec Life Ltd. Pipeline Products & Ongoing Clinical Trials Overview 150

Amniotic Fluid Leakage Diagnosis Device – Product Status 150

Amniotic Fluid Leakage Diagnosis Device – Product Description 150

Myant Inc Pipeline Products & Ongoing Clinical Trials Overview 151

SKIIN Smart – Ovulation Monitoring – Product Status 151

SKIIN Smart – Ovulation Monitoring – Product Description 151

Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 152

Urination Management System – Product Status 152

Urination Management System – Product Description 152

NaturalCycles Nordic AB Pipeline Products & Ongoing Clinical Trials Overview 153

Wearable Birth Control App – Product Status 153

Wearable Birth Control App – Product Description 153

NipaYe Pipeline Products & Ongoing Clinical Trials Overview 154

AKOMA – Product Status 154

AKOMA – Product Description 154

Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 155

Sperm Injection Catheter – Product Status 155

Sperm Injection Catheter – Product Description 155

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 156

Implantable Ovary Bioscaffold – Product Status 156

Implantable Ovary Bioscaffold – Product Description 156

Uterine Cervix Continual Assessment Device – Product Status 157

Uterine Cervix Continual Assessment Device – Product Description 157

Novela Inc Pipeline Products & Ongoing Clinical Trials Overview 158

Wearable Pregnancy Monitoring Device – Product Status 158

Wearable Pregnancy Monitoring Device – Product Description 158

Noventure SL Pipeline Products & Ongoing Clinical Trials Overview 159

Ginuril – Product Status 159

Ginuril – Product Description 159

OB Smart Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

OB Smart Device – Product Status 160

OB Smart Device – Product Description 160

ObsteCare AB Pipeline Products & Ongoing Clinical Trials Overview 161

AFL Monitoring System – Product Status 161

AFL Monitoring System – Product Description 161

Obstetrx Inc Pipeline Products & Ongoing Clinical Trials Overview 162

XSTAT PPH – Product Status 162

XSTAT PPH – Product Description 162

OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 163

Vaginal Microbiome Dysbiosis Device – Product Status 163

Vaginal Microbiome Dysbiosis Device – Product Description 163

OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 164

CerCap HIV – Product Status 164

CerCap HIV – Product Description 164

Ondine Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 165

Vitalwave – Product Status 165

Vitalwave – Product Description 165

Onko Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 166

InstaPAP – Product Status 166

InstaPAP – Product Description 166

Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

OB-002 IVR – Product Status 167

OB-002 IVR – Product Description 167

PEPTONIC medical AB Pipeline Products & Ongoing Clinical Trials Overview 168

Vagivital – Bacterial Vaginosis – Product Status 168

Vagivital – Bacterial Vaginosis – Product Description 168

Vagivital – Fungal Infections – Product Status 169

Vagivital – Fungal Infections – Product Description 169

VagiVital Aktivgel – Product Status 170

VagiVital Aktivgel – Product Description 170

PEPTONIC medical AB – Ongoing Clinical Trials Overview 171

VagiVital Aktivgel – Study Evaluating the Efficacy of VagiVital AktivGel for the Treatment of Vaginal Fungal Infections 172

Pink Luminous Breast Pipeline Products & Ongoing Clinical Trials Overview 173

PLB Device – Product Status 173

PLB Device – Product Description 173

Polumiros Inc Pipeline Products & Ongoing Clinical Trials Overview 174

ReFilx – Product Status 174

ReFilx – Product Description 174

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

NovoSorb – Breast Reconstruction – Product Status 175

NovoSorb – Breast Reconstruction – Product Description 175

Positive Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

Breast Milk Pump – Product Status 176

Breast Milk Pump – Product Description 176

PregnanTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 177

Lioness – Product Status 177

Lioness – Product Description 177

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 178

Wearable Device – Preeclampsia – Product Status 178

Wearable Device – Preeclampsia – Product Description 178

Qurasense Inc Pipeline Products & Ongoing Clinical Trials Overview 179

Q-pad – Cervical Cancer – Product Status 179

Q-pad – Cervical Cancer – Product Description 179

Q-pad – Diabetes – Product Status 180

Q-pad – Diabetes – Product Description 180

Q-pad – Fertility and Fasting Cholesterol – Product Status 180

Q-pad – Fertility and Fasting Cholesterol – Product Description 181

Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 182

Breast Clips – Product Status 182

Breast Clips – Product Description 182

Reia LLC Pipeline Products & Ongoing Clinical Trials Overview 183

Collapsible Vaginal Pessary – Product Status 183

Collapsible Vaginal Pessary – Product Description 183

Rejoni Inc Pipeline Products & Ongoing Clinical Trials Overview 184

Intrauterine Interventional Device – Scars – Product Status 184

Intrauterine Interventional Device – Scars – Product Description 184

Renovia Inc Pipeline Products & Ongoing Clinical Trials Overview 185

Lift – Product Status 185

Lift – Product Description 185

PFDx – Product Status 186

PFDx – Product Description 186

wPFDx – Product Status 186

wPFDx – Product Description 186

Renovia Inc – Ongoing Clinical Trials Overview 187

PFDx – Validity (and Reliability) of Two Forms of an Accelerometer-based Intravaginal Device for Detecting Pelvic Floor Motion 188

Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 189

Breast Displacement Measuring Device – Product Status 189

Breast Displacement Measuring Device – Product Description 189

Rice University Pipeline Products & Ongoing Clinical Trials Overview 190

Nutriflow Device – Product Status 190

Nutriflow Device – Product Description 190

Uterine Contraction Monitor – Product Status 191

Uterine Contraction Monitor – Product Description 191

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 192

Pre-eclampsia Sensing Strip – Product Status 192

Pre-eclampsia Sensing Strip – Product Description 192

Starpharma Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 193

VivaGel BV – Product Status 193

VivaGel BV – Product Description 193

TCM Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 194

Gynpad – Product Status 194

Gynpad – Product Description 194

Tecuro AG Pipeline Products & Ongoing Clinical Trials Overview 195

U-med Pad – Product Status 195

U-med Pad – Product Description 195

TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 196

Skin Printer – Product Status 196

Skin Printer – Product Description 196

TeVido Breast Graft – Product Status 197

TeVido Breast Graft – Product Description 197

The Cooper Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 198

SMART Start Embryo Culture System – Product Status 198

SMART Start Embryo Culture System – Product Description 198

The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 199

Gelift – Product Status 199

Gelift – Product Description 199

TruScreen Ltd Pipeline Products & Ongoing Clinical Trials Overview 200

TruScreen Ultra – Product Status 200

TruScreen Ultra – Product Description 200

University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 201

FemFit Device – Product Status 201

FemFit Device – Product Description 201

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 202

Smart Diaphragm – Product Status 202

Smart Diaphragm – Product Description 202

University of Duisburg-Essen Pipeline Products & Ongoing Clinical Trials Overview 203

Mammary Immobilization Device – Product Status 203

Mammary Immobilization Device – Product Description 203

University of Erlangen-Nurnberg Pipeline Products & Ongoing Clinical Trials Overview 204

Artificial Ovary – Product Status 204

Artificial Ovary – Product Description 204

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 205

Labor Pain Management System – Product Status 205

Labor Pain Management System – Product Description 205

Uterine Activity Maps – Labor – Product Status 206

Uterine Activity Maps – Labor – Product Description 206

University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 207

The PPH Butterfly – Product Status 207

The PPH Butterfly – Product Description 207

University of Liverpool – Ongoing Clinical Trials Overview 208

The PPH Butterfly – An Open Label, Phase II, Un-randomized trial of a Novel Medical Device to Manage Post-partum Haemorrhage with Historical Controls 209

University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 210

Extrial Infant Pre-maturity Related Disorder Predictor – Product Status 210

Extrial Infant Pre-maturity Related Disorder Predictor – Product Description 210

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 211

Vaginal Dilation And Flushing Device – Product Status 211

Vaginal Dilation And Flushing Device – Product Description 211

Wearable Breast Pump – Product Status 212

Wearable Breast Pump – Product Description 212

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 213

VASFAS – Product Status 213

VASFAS – Product Description 213

University of Sheffield Pipeline Products & Ongoing Clinical Trials Overview 214

Electrical Impedance Spectroscopy Based Device – Preterm Birth – Product Status 214

Electrical Impedance Spectroscopy Based Device – Preterm Birth – Product Description 214

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 215

Hydrocolloid Bra – Product Status 215

Hydrocolloid Bra – Product Description 215

Mesh Positioning And Retention System – Product Status 216

Mesh Positioning And Retention System – Product Description 216

Sterile Uterine Sampler Cover Device – Product Status 216

Sterile Uterine Sampler Cover Device – Product Description 217

Transvaginal Specimen Extraction Device – Product Status 217

Transvaginal Specimen Extraction Device – Product Description 217

University of Technology of Compiegne Pipeline Products & Ongoing Clinical Trials Overview 218

Tuli – Product Status 218

Tuli – Product Description 218

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 219

Screening Tool – Pregnancy – Product Status 219

Screening Tool – Pregnancy – Product Description 219

University of Waterloo Pipeline Products & Ongoing Clinical Trials Overview 220

HIV Prevention Device – Product Status 220

HIV Prevention Device – Product Description 220

VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 221

Pressure-Sensing Microtransponder – Product Status 221

Pressure-Sensing Microtransponder – Product Description 221

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 222

Nuzzi – Product Status 222

Nuzzi – Product Description 222

VivoPlex Ltd Pipeline Products & Ongoing Clinical Trials Overview 223

Wireless Womb Monitoring Device – Product Status 223

Wireless Womb Monitoring Device – Product Description 223

VivoPlex Ltd – Ongoing Clinical Trials Overview 224

Wireless Womb Monitoring Device – Evaluate the Safety and Effectiveness of the Wireless Womb Monitoring Device 225

Wireless Womb Monitoring Device – First Clinical Feasibility Study of Wireless Uterine Sensor in Women 225

Wave Intelligence Inc Pipeline Products & Ongoing Clinical Trials Overview 226

Breast Cancer Screening Device – Product Status 226

Breast Cancer Screening Device – Product Description 226

Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview 227

ZP-025 – Product Status 227

ZP-025 – Product Description 227

ZR-Operculum, Inc. Pipeline Products & Ongoing Clinical Trials Overview 228

ZRO Device – Product Status 228

ZRO Device – Product Description 228

Figures

Women’s Health Devices – Pipeline Products by Stage of Development 23

Women’s Health Devices – Pipeline Products by Territory 24

Women’s Health Devices – Pipeline Products by Regulatory Path 26

Women’s Health Devices – Pipeline Products by Estimated Approval Date 28

Frequently asked questions

Women’s Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Women’s Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Medical Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Women’s Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Women’s Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more